A variant of Smurf2 protects mice against colitis-associated colon cancer by inducing transforming growth factor β signaling.


Abstract

T cell-specific ΔE2Smurf2 degrades wild-type Smurf2 and controls intestinal tumor growth in mice by up-regulating TGF-β receptor type II, reducing proliferation and production of proinflammatory cytokines.


Full Text


Subjects


Similar articles

Español | English

© Galenicom 1999-2013